IQVIA
IQV
#584
Rank
NZ$73.90 B
Marketcap
NZ$448.46
Share price
-1.89%
Change (1 day)
15.50%
Change (1 year)

Earnings for IQVIA (IQV)

Earnings in 2026 (TTM): NZ$4.08 Billion

According to IQVIA's latest financial reports the company's current earnings are NZ$17.31 Billion. In 2025 the company made an earning of NZ$4.23 Billion a decrease over its 2024 earnings that were of NZ$4.26 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for IQVIA from 2012 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) NZ$4.08 B-3.45%
2025 NZ$4.23 B-0.81%
2024 NZ$4.26 B9.76%
2023 NZ$3.88 B19.79%
2022 NZ$3.24 B18.36%
2021 NZ$2.74 B90.49%
2020 NZ$1.43 B-1.25%
2019 NZ$1.45 B7.68%
2018 NZ$1.35 B6.61%
2017 NZ$1.26 B11.74%
2016 NZ$1.13 B-2.79%
2015 NZ$1.16 B6.31%
2014 NZ$1.09 B34.96%
2013 NZ$0.81 B11.16%
2012 NZ$0.73 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Nymox Pharmaceutical
NYMX
-NZ$3.95 Million-100.09% Bahamas
NRC Health
NRC
NZ$26.98 M-99.37%๐Ÿ‡บ๐Ÿ‡ธ USA